Genetic ablation, as well as pharmacological inhibition of NetG1, were not only able to retard tumor progression, they were also able to alleviate the immunosuppressive TME phenotype through recovery of NK cell-mediated tumor surveillance. The gene discussed is NTNG1; the disease is neoplasm.